Citations

Clear

4610 citation(s) found for "Lu, Brian".

Radiomics-Based Prediction of Local Recurrence after Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer
Ogbonna, Chioma P, Breen, William G. , Noach, P., Rajagopalan, Srinivasan , Hostetter, Logan , Maldonado, Fabien , Bartholmai, Brian J. , Merrell, Kenneth W. , Peikert, T., Bartholmai, Brian J

Mayo Clinic

Annals of the American Thoracic Society | April 10, 2025 | Volume: 22 | Issue: 8 | Pages: 1236-1243

10.1513/annalsats.202410-1047oc | PMID 40208641 Get It

Abstract Rationale Stereotactic body radiation therapy (SBRT) represents an effective therapeutic strategy for early-stage non–small cell lung cancer (NSCLC); however, local and systemic recurrences represent ongoing challenges. Computed tomography (CT) radiomics-based risk models can potentially be used to predict the risk of local recurrence on pretreatment CT scans. Objective Development of a radiomics model to predict local recurrence after SBRT in patients with NSCLC. Methods This single-institution study includes a retrospective case-control training set (20 patients with local recurrence and 40 control subjects) and an independent validation set (198 consecutive cases) of patients with early-stage NSCLC treated with SBRT. Tumors were semiautomatically segmented, and 102 quantitative radiomic features, including texture, landscape, spatial, nodule shape, and nodule surface features, were extracted. These features were included in three separate multivariable models to predict the risk of recurrence on the basis of pre-SBRT, post-SBRT, and the difference between the pre-SBRT and post-SBRT scans (Delta model). The pre-SBRT model was subsequently validated in an independent validation set. Results Thirteen independent variables were selected for the models using the Boruta algorithm. The sensitivity, specificity, and area under the curve of the pre-SBRT, post-SBRT, and Delta models were 85%, 90%, and 0.91; 85%, 92.5%, and 0.92; and 85%, 92.5%, and 0.94, respectively. The pre-SBRT model was validated in the independent validation set (area under the curve, 0.89; confidence interval, 0.83–0.92), because this model was believed to be the most useful to assist in individualized treatment planning. Conclusions Radiomic analysis facilitated the development of three high-performing models predicting local recurrence using either pre-SBRT CT, post-SBRT CT, or the change between these two. We successfully validated the most clinically relevant model, the pre-SBRT model. Although this model needs further validation, it may facilitate individualized surveillance, treatment planning, and selection of adjuvant therapy.
Noninvasive brain stimulation as focal epilepsy treatment in the hospital, clinic, and home
Islam, Karimul , Starnes, Keith , Smith, Kelsey M. , Gregg, Nicholas M. , Worrell, Gregory A. , Lundstrom, Brian N. , Richner, Thomas, Gregg, Nicholas M , Worrell, Gregory A , Lundstrom, Brian Nils , Smith, Kelsey M , Starnes, Donnie Keith , Islam, Karimul , Richner, Thomas J. , Rabinstein, Alejandro A.

Mayo Clinic

Epilepsia Open | April 10, 2025 | Volume: 10 | Issue: 3 | Pages: 787-795

10.1002/epi4.70033 | PMID 40208019 Get It

Abstract Objective Noninvasive brain stimulation (NIBS) provides a treatment option for patients not eligible for surgical intervention or who seek low‐risk approaches and may be used in the hospital, clinic, and at home. Our objective is to summarize our single‐center experience with multiple NIBS approaches for the treatment of focal epilepsy. Methods A retrospective chart review identified drug‐resistant focal epilepsy patients who received NIBS as an epilepsy treatment at Mayo Clinic in Rochester, MN. Patients were typically treated as follows: (1) for TMS, 1 Hz stimulation was applied for five consecutive days in the neuromodulation clinic, (2) for outpatient tDCS, stimulation was applied for five consecutive days in the clinic, followed by optional treatment at home, and (3) for inpatient tDCS, stimulation was applied for three consecutive days. We analyzed continuous EEG data for the inpatient tDCS cohort and available HD‐EEG data for outpatient cohorts to quantify changes in interictal epileptiform discharges (IEDs) as a result of stimulation. Outcomes were assessed at 1 month for TMS and outpatient tDCS and 1 week for inpatient tDCS. Results Twenty‐four patients were treated with TMS ( n = 10) and tDCS ( n = 14, 9 as outpatients). The median age was 40 years (range 15–73). The median seizure reduction following stimulation was 50%. Fourteen patients (58%) were responders to treatment (TMS = 4/10, tDCS Outpatient = 7/9, tDCS Inpatient = 3/5). Five outpatient tDCS participants elected to continue treatment at home. Four TMS and four outpatient tDCS patients underwent high‐density EEG before and after 5 days of therapy. Following stimulation, IED rate was reduced in 4/5 inpatient tDCS patients, 4/4 outpatient tDCS patients, and 4/4 TMS patients. Two patients experienced an increase in seizure frequency (1 following TMS and 1 following outpatient tDCS), which returned to baseline 4–6 weeks after stimulation treatments were discontinued. Significance TMS and tDCS are potential treatment approaches for drug‐resistant focal epilepsy patients in the hospital, clinic, and home. They have a favorable safety profile and can lead to a reduction in IED rates and seizures. These results suggest further studies are needed to examine NIBS as a treatment for epilepsy. Plain Language Summary Noninvasive brain stimulation, such as transcranial magnetic stimulation and transcranial direct current stimulation, offers new treatment options for patients with focal seizures. This study reviewed the experience at Mayo Clinic using noninvasive brain stimulation in the hospital, clinic, and at‐home settings to treat seizures. The results showed an overall 50% median seizure reduction, and 58% of patients had at least a 50% reduction in seizures. Noninvasive brain stimulation is a promising treatment approach with a favorable safety profile.
Bone Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Biermann, J. Sybil, Boles, Sarah G , Brigman, Brian E. , Callan, Alexandra K. , Cranmer, Lee D., Davis, Jessica , Donnelly, Eric D. , Ferguson, Michael J. , Graham, Ann, Groundland, John , Hess, Matthew, Hiniker, Susan M. , Hoover‐Regan, Margo , Jonard, Brandon , Lindskog, Dieter M. , Mayerson, Joel , McGarry, Sean V., Olson, Daniel J. , Rose, Peter S. , Santana, Victor M. , Satcher, Robert L. , Schwartz, Herbert S. , Shulman, Rebecca M. , Wustrack, Rosanna , Yoon, Janet, Hang, Lisa E., Jones, Frankie, Sansone, Nicholas, Lyons, Megan , Hirbe, Angela C. , Ahlawat, Shivani , Bernthal, Nicholas M , Binitie, Odion , Cipriano, Cara A. , Cranmer, Lee D. , Graham, Ann, Hess, Matthew, Hornick, Jason L. , Kuechle, Joseph , Morris, Carol D. , Thorpe, Steven W. , Wilky, Breelyn A , Lyons, Megan

Mayo Clinic

Journal of the National Comprehensive Cancer Network | April 9, 2025 | Volume: 23 | Issue: 4 | Pages: No page available

10.6004/jnccn.2025.0017 | PMID 40203873 Get It

Ewing sarcoma and osteosarcoma constitute 36% of all primary bone cancers. However, these 2 subtypes represent the most commonly diagnosed bone cancer types in the pediatric and adolescent population. Although still largely unknown, certain genetic mutations, rearrangements, and/or predisposition syndromes likely play a role in the pathogenesis of bone cancer. Osteosarcoma may also develop as a direct result of the long-term side effects of radiation therapy. With the implementation of a multimodality approach to treatment, including multiagent neoadjuvant and adjuvant chemotherapy regimens, targeted therapy options, surgery, and radiation, individuals with Ewing sarcoma and osteosarcoma are showing higher cure rates and improved overall survival. The NCCN Guidelines for Bone Cancer provide a consensus and evidence-based framework for the workup, management, and surveillance of local and recurrent/metastatic disease.
ICU Provider Perspectives on EHR Usability
Khairat, Saif , Morelli, Joseph G. , Strechen, Inna , Pickering, Brian W. , Khairat, Saif , Morelli, Jennifer , Herasevich, Vitaly

Mayo Clinic

Studies in Health Technology and Informatics | April 8, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3233/shti250075 | PMID 40200472 Get It

Poorly designed Electronic Health Records (EHRs) can lead to increased workloads, decreased efficiency, and medical errors. This cross-sectional study surveyed ICU providers’ perceptions of their EHR using the NASA-TLX and CSUQ surveys. We found that providers report increased temporal demand and effort when using the EHR, and that they are dissatisfied with the EHR’s interface quality.
Towards a Standardized Process of Onboarding Advanced Practice Providers into Headache Medicine Practices in the United States (P1-12.009)
Freeman, Marshall C., Cook, Calli , Ehrlich, Annika, Grosberg, Brian M. , Samaha, M , Moriarty, Maureen, Secora, Karissa , Birlea, Laur Marius, Ailani, Jessica , VanderPluym, Juliana H.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000208577 Get It

FDG-PET Patterns Associate With Survival in Patients With Prion Disease (P4-3.005)
Day, Gregory S. , Piura, Yoav , Shir, Dror , Barnard, Leland R , Gogineni, Venkatsampath, Jones, David , Day, Gregory S , Shir, Dror , Corriveau‐Lecavalier, Nick , Appleby, Brian S.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000209017 Get It

Seizure Laterality on EEG is Associated with Thalamic SPECT Lateralization (P4-9.007)
Tanwir, Asra, Mandrekar, Jay , So, Elson, Ortiz‐Guerrero, Gloria , Burkett, Brian J. , So, Elson L., Gompel, Jamie J. Van , Brinkmann, Benjamin H.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210738 Get It

Palliative Care Access in Patients with Prion Disease (P3-11.005)
Zayat, Roaa , Piura, Yoav , Robinson, Maisha T. , Day, Gregory, Day, Gregory S. , Day, Gregory S , Appleby, Brian S.

Mayo Clinic

Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000210544 Get It